baber/WOPTO huggingface dataset:
Patent AT-E187516-T1 (AT)
Inventor: MANZIN SERGIO
IPC: E02B15/04
Filed: 1995-09-26
Granted: 1999-12-15
Abstract: A quick assembly device for pollutant barriers made of a flexible pipe (2) to be partially filled with liquids and partially filled with gas consists of a system with mainly two components. The first component is a flexible pipe (2) folded upon itself and subdivided into two compartments and the second component is a multiple-chamber container (1) that is equipped with a blocking and filling device and that also takes up the function of an anchoring buoy. The multiple possibilities of use of its components, that allow the pipe (2) to be drawn and loaded at the same time just by trailing the container (1) in water by means of ropes, confer various advantages to the device. Considerable lengths of pollutant barriers may be orderly stored in a concentrated and well delimited manner inside practical and light containers. Recycling of the barrier may be dispensed with, thanks to lower operational and material costs, so that large scale interventions at considerable distances are possible and large pollutant surface areas may be controlled to assist in successive interventions. The pipe may be used to store liquid pollutants.
Patent AT-E203539-T1 (AT)
Inventor: NELSON FRANCES CHRISTY
IPC: A61K31/435
Filed: 1995-11-22
Granted: 2001-08-15
Abstract: A compound of the structure   <IMAGE>   wherein R and R1 are each, independently,   <IMAGE>   or hydrogen; R2 and R3 are each, independently, alkyl, arylalkyl , or R2 and R3 may be taken together to form a cycloalkyl ring; R4 is a heterocyclic N-oxide radical, which may be optionally substituted; R5 is alkyl or arylalkyl; R6 and R7 are taken together to form a saturated N-alkyl-heterocyclic N-oxide, which may be optionally substituted; k=0-1, m=0-1; n=1-6; with the proviso that R and R1 are not both hydrogen, which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
Patent AT-E171884-T1 (AT)
Inventor: SENTAGNES DOMINIQUE
IPC: A62D3/37
Filed: 1995-12-05
Granted: 1998-10-15
Abstract: PCT No. PCT/FR95/01600 Sec. 371 Date Jul. 24, 1997 Sec. 102(e) Date Jul. 24, 1997 PCT Filed Dec. 5, 1995 PCT Pub. No. WO96/17680 PCT Pub. Date Jun. 13, 1996Chemical transformation of complex chemical structures in a supercritical medium. The transformation of one or more chemical structures (20) involves at least one reduction reaction in a solvent (22) in the supercritical state. Application to the destruction of dangerous products, the treatment of industrial effluents and natural products and the modification of molecular structures.
Patent AT-E173474-T1 (AT)
Inventor: FINGRHUT HELMUT
IPC: C07D251/62
Filed: 1995-12-13
Granted: 1998-12-15
Abstract: In a melamine purifying process, impure melamine is heated up to a temperature above 200  DEG C but below the ammonia pressure-dependent, momentary melting point of melamine, and is kept in a solid state in said temperature range under an ammonia pressure from 5 to 350 bars for a period from 1 minute to 20 hours. It is then expanded and cooled down to room temperature, in whatever order, to produce pure melamine in powder form.
Patent AT-E252220-T1 (AT)
Inventor: RAINES HENRY H
IPC: C06B23/04
Filed: 1995-11-30
Granted: 2003-11-15
Abstract: There is provided a decoppering agent that is added to a propellant charge to remove copper from the rifling of the internal bore of a gun barrel. The decoppering agent consists essentially of a lead-free pulverized additive dispersed in a combustible binder. One suitable decoppering agent is pulverized bismuth metal, dispersed in a nitrocellulose binder. The bismuth metal either vaporizes or liquifies when the propellant charge is ignited and either embrittles or dissolves the copper deposits facilitating removal.
Patent AT-E213840-T1 (AT)
Inventor: AMAN JAMES A
IPC: B65G1/00
Filed: 1995-12-14
Granted: 2002-03-15
Abstract: On Fork Lift 100, Load Cell Assemblies 40a and 40b are affixed to Fork Arms 32a and 32b and as such are capable of determining the weight of any object lifted by Fork Arm Lift Assembly 30. Continuous weight information is transmitted from Assemblies 40a and 40b to Fork Lift Computer 52 via wires and IR Transmitter 44 and Receiver 48. Changes in weight information are interpreted as load engagement and disengagement by Computer 52, which then responds by receiving the current relative vertical height of Fork Arm Lift Assembly 30 from Ultrasonic Distance Measuring Unit 56. The Computer 52 then transmits, via Telescoping Antenna 70, an uniquely encoded signal with both weight and height information to Stationary Elevated Locating Modules such as 74a and 74b, which have been strategically placed throughout the operating range of Fork Lift 100. This signal is then transmitted to Unit Tracking Computer System 80 by Locating Modules such as 74a and 74b. Using conventional tracking technology, the Computer System 80 determines the current x-y coordinates of transmitting Fork Lift 100 and communicates this information along with the transmitted z coordinate and weight to the Office Computer System 84. Computer System 84 is capable of storing this information is a database of like information for the purposes of tracking the exact three dimensional location and weight of the objects which are being moved by vehicles such as Fork Lift 100.
Patent AT-E203153-T1 (AT)
Inventor: GRIMM MANFRED
IPC: A61G12/00
Filed: 1996-04-02
Granted: 2001-08-15
Abstract: A supply unit for sickness room includes a supply box (10) for receiving gas- and current-lines with the lower face of the supply box designed as a fitment wall (23) for the connection (terminal) devices (24). A lighting unit (30) extends along the supply box (10).   The lighting unit (30) is designed as a separate unit placed in front of the supply box (10), which abuts against an equipment wall (29) of the supply box (10) offset from the fitment wall (23) and which can be continuously displaced along the equipment wall (29).
Patent AT-E205240-T1 (AT)
Inventor: INAGI TOSHIO
IPC: A61K9/70
Filed: 1996-06-25
Granted: 2001-09-15
Abstract: Described is a hydrophilic adhesive base material comprising a hydrophilic crosslinked polymer obtained by polymerizing (A) (a) a glucosyloxyalkyl (meth)acrylate, (b) an alkyl (meth)acrylate and/or a hydroxyalkyl (meth)acrylate and (c) a polyfunctional monomer; and (B) polyvinyl alcohol. The hydrophilic adhesive base material according to the present invention is free from lowering in the water content and has excellent mechanical strength and adhesion to the skin so that it is useful as adhesive layers in plasters, various medical pads and also medicament-impregnated dermatologic medicines.
Patent AT-E202734-T1 (AT)
Inventor: FOLTIN HORST
IPC: B22C3/00
Filed: 1996-09-26
Granted: 2001-07-15
Abstract: Models for full mould casting of metals by the lost model process are made by using as essential component a substance that is fully degradable by natural means (e.g. biological attack or exposure to light).
Patent AT-E293699-T1 (AT)
Inventor: GOFF STEPHEN ARTHUR
IPC: A01H5/00
Filed: 1996-02-19
Granted: 2005-05-15
Abstract: The present invention is drawn to a method of controlling gene expression in plants. Specifically, the method comprises obtaining a transgenic plant comprising at least two receptor expression cassettes and at least one target expression cassette. The first receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a first receptor polypeptide, and a 3' termination region. The second receptor expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a second receptor polypeptide, and a 3' termination region. The target expression cassette comprises a nucleotide sequence for a 5' regulatory region operably linked to a nucleotide sequence which encodes a target polypeptide, and a 3' termination region, wherein the 5' regulatory region of the target expression cassette is activated by the first and second receptor polypeptides in the presence of one or more chemical ligands which are complementary to the ligand binding domain of the receptor polypeptides, whereby expression of the target polypeptide is accomplished. The method is useful for controlling various traits of agronomic importance, such as plant fertility.
Patent AT-E210483-T1 (AT)
Inventor: SCHALLER EARLE
IPC: B01D21/02
Filed: 1996-01-17
Granted: 2001-12-15
Abstract: A vented baffle system for use in a clarifier tank having a tank bottom, a periphery and a substantially vertical peripheral wall bounding the interior of the tank is formed by a plurality of individual and cooperatively-engageable baffles mounted on the peripheral tank wall. Each baffle includes a panel member that downwardly slopes from the peripheral tank wall toward the interior of the tank and the tank bottom and terminates at a lower edge disposed in space relation above the tank bottom. A first lateral end of the panel member unitarily carries an end bracket securable to the peripheral wall for supporting the panel member in a cantilevered fashion. One or more of the baffles are provided with a relief valve means for venting the pressure in a space formed between the junction of the lower side of the panel member and the peripheral tank wall. The resulting system provides a vented baffle system in which pressure exerted by the build up of gases in the space may be alleviated.
Patent AT-E185043-T1 (AT)
Inventor: MEYER TERRY E
IPC: A01N27/00
Filed: 1996-05-24
Granted: 1999-10-15
Abstract: Limonene is effective in controlling Southern corn rootworm. It can be applied as a conventional insecticide, or plants can be transformed with a gene which codes for an enzyme which synthesizes limonene from a substrate available in the plant. Transformed plants are resistant to infestation by Southern corn rootworm.
Patent AT-E321128-T1 (AT)
Inventor: LUDMERER STEVEN
IPC: C12N7/00
Filed: 1996-07-15
Granted: 2006-04-15
Abstract: The present invention is a series of synthetic virus-like particles useful in the characterization of human papillomavirus infection and assays employing the synthetic virus-like particles.
Patent AT-E232497-T1 (AT)
Inventor: GRETENER URS
IPC: B65G47/70
Filed: 1996-09-05
Granted: 2003-02-15
Abstract: PCT No. PCT/CH96/00305 Sec. 371 Date Jun. 26, 1997 Sec. 102(e) Date Jun. 26, 1997 PCT Filed Sep. 5, 1996 PCT Pub. No. WO97/09256 PCT Pub. Date Mar. 13, 1997Process and apparatus for controlling the channeling of parceled goods to be delivered via a delivery conveyor, which includes at least one buffer conveyor, a call-up conveyor, and a channeling conveyor, to free locations on an acceptance conveyor running at a constant speed. The acceptance conveyor and the delivery conveyor are arranged to encompass an angle  alpha , and the delivery conveyor is provided with a parcel measuring device. The process includes measuring a length of a parcel to be channeled, determining a length of time t2 utilized in measuring the length of the parcel, and determining a momentary parcel speed; a speed of the channeling conveyor to which the parcel will be transferred; a distance on the call-up conveyor on which acceleration of the parcel occurs prior to a transfer of the parcel to the channeling conveyor; and a position of a next free space on the acceptance conveyor. The process also includes synchronizing movement of the parcel to the next free space by one of (a) accelerating and decelerating and (b) decelerating and accelerating the parcel on the call-up conveyor at a constant acceleration a, and without intermediate stopping of the call-up conveyor, transferring the parcel from the call-up conveyor to the channeling conveyor, and synchronously transferring the parcel to the next free space on the acceptance conveyor. The apparatus includes a measuring device to measure a length of a parcel to be transferred from the delivery conveyor to the acceptance conveyor, wherein the measurement of the length occurs in a time t2, a control device provided for determining a momentary speed of parcel; a speed of the channeling conveyor to which the parcel will be transferred; a distance on the call-up conveyor on which acceleration of the parcel occurs prior to a transfer to the channeling conveyor; and a position of a next empty space on the acceptance conveyor. The control device also is provided to adjust one of (a) an acceleration and deceleration and (b) a deceleration and acceleration of the parcel on the call-up conveyor, without intermediate stopping of the call-up conveyor, to synchronize the movement of the parcel to the next empty space on the acceptance conveyor.
Patent AT-E186209-T1 (AT)
Inventor: ASMUSSEN BODO
IPC: A61K9/06
Filed: 1996-09-21
Granted: 1999-11-15
Abstract: A therapeutic preparation for the transdermal application of active substances through the skin comprising additives causing an increase in the percutaneous absorption rate of active substances which can normally only insufficiently be absorbed transdermally is characterized by the fact that the additives are HMG-CoA-reductase-inhibitors.
Patent AT-E299707-T1 (AT)
Inventor: VOERMAN GERARD
IPC: A61K31/00
Filed: 1996-11-13
Granted: 2005-08-15
Abstract: Methods substances and composition derived from leeches, bacteria associated with leeches, or combinations thereof are provided to prevent retroviral infections of host cells. More particularly, the invention relates to the inhibition of HIV replication. Thus the invention provides methods and substances for treating and/or preventing HIV infection and/or AIDS. The compounds or mixtures are obtainable by solvent extraction techniques and separation steps and were tested in the following manner. Two syncytium-forming HIV isolates HIV AMS55 and HIV Ams37 were inoculated in PBMC and monocytes. During 14 days HIV induced cytopathic effects (CPE) (syncytium formation) and the virus production as determined by a p24 capture ELISA was monitored, after addition of leech head extracts. The results of these tests with the partly purified HIV inhibiting substance or substances is as follows: 3 fractions inhibited both syncytium formation and p24 antigen by 100% at a concentration of: 0.67 muM, 0.5 muM and 0.17 muM respectively in both HIV isolates. A fourth fraction underwent dilution series and inhibited both CPE and p-24 antigen 100% from 0.5 muM upwards in both HIV isolates.
Patent AT-E179695-T1 (AT)
Inventor: KRUEGER BENNO DR
IPC: C08F20/68
Filed: 1997-10-30
Granted: 1999-05-15
Abstract: Bicyclo-Ä2.2.2Ü-2,3:5,6-dibenzocta-2,5-diene-7-carboxylicacid alkenyl ester monomers of formula (I) is new, in which Ra, Rb = H or R; R = branched or unbranched 1-8C alkyl or cycloalkyl; Rc = H or 1-4C alkyl; and S = H, R, OR, COOR or COR. Also claimed are (i) the production of (I) by trans-vinylation of the corresponding carboxylic acids (II) with vinyl esters of 1-8C alkanoic acids or vinyl chloride in presence of stabilisers and catalysts; (ii) copolymers of vinyl esters (I) with other unsaturated ethylenic comonomer(s); and (iii) the production of these copolymers by bulk, solution, suspension or emulsion polymerisation.
Patent AT-E210550-T1 (AT)
Inventor: GILLIARD PIERRE
IPC: B29C55/00
Filed: 1997-09-19
Granted: 2001-12-15
Abstract: Process making use of semi-crystalline thermoplastic polymer comprises extruding thermoplastic and cooling it to temperature T1, where T1 > crystallisation temperature, Tc and < Tf + 5 degrees C, Tf = melting point of thermoplastic; stretching extrudate; allowing extrudate to relax at temperature T3, where Tc < T3 < Tf, for time = average relaxation time of thermoplastic; and soaking extrudate at temperature T4, where T4 < Tc. Also claimed is film made by said process.
Patent AT-E210354-T1 (AT)
Inventor: KORI TERUHIKO
IPC: H04N5/91
Filed: 1997-04-14
Granted: 2001-12-15
Abstract: Regular burst signals from video line (n+0) to line (n+3) are replaced by modified burst signals which function as copy prohibit signals. The phase of the modified burst signals is controlled by controlling at least one of the orthogonal vectors into which the phase of the regular burst signal is resolved, and the phase vector of the modified burst signals is equal to the average value of the phase vector of the regular burst signals in lines (n+0) through (n+3). The phase vector of the modified burst signal in line (n+2) exhibits a phase difference of 135 DEG  from the phase vector of the original regular burst signal in that line and causes image disturbances when the thus-modified video signal is recorded and reproduced by a VCR. The phase vector of the modified burst signal in each of lines (n+0), (n+1) and (n+3) exhibits a difference as small as 45 DEG  from the phase vector of the original regular burst signal in those lines. <IMAGE>
Patent AT-E203210-T1 (AT)
Inventor: HOLLENSTEIN HANS
IPC: B42B2/02
Filed: 1997-09-15
Granted: 2001-08-15
Abstract: The method involves feeding printed sheets (3) into a stitching unit which has at least one stitcher with a first (5) and second (6) driven sewing needle to form two seams on the spine of the inner book. A saddle-type, clocked, driven stitching table contains an outlet of a gas pipe (18) connected to a pressure source, and directed at a section of the binding thread forming an open loop (21), and at the track along which the second sewing needle moves. Two guide pieces (23) form a guide and are on both sides of a plane formed through the stitching needles.
Patent AT-E196491-T1 (AT)
Inventor: QURESHI SHAHID P
IPC: C08G12/40
Filed: 1997-07-08
Granted: 2000-10-15
Abstract: An aqueous composition containing an acid-hardenable melamine-formaldehyde resin and a nitrogen-containing acidic phosphorus curing agent made from either phosphoric acid or phosphorous acid which is curable to an intumescent composition.
Patent AT-E251153-T1 (AT)
Inventor: AMSCHLER HERMANN
IPC: A61K31/427
Filed: 1997-08-13
Granted: 2003-10-15
Abstract: PCT No. PCT/EP97/04435 Sec. 371 Date Feb. 26, 1999 Sec. 102(e) Date Feb. 26, 1999 PCT Filed Aug. 13, 1997 PCT Pub. No. WO98/08841 PCT Pub. Date Mar. 5, 1998Compounds having the formula (I): wherein R1, R2, R3, R4, R5 and n have the meanings given in the description. The compounds of formula (I) are selective inhibitors of phosphodiesterase IV.
Patent AT-E204196-T1 (AT)
Inventor: FICSOR ISTVAN
IPC: B01D24/00
Filed: 1997-09-05
Granted: 2001-09-15
Abstract: A base is disclosed for a filter container and a pump for displacing liquids that flow through the filter container. In order to provide a common base for the filter container and a pump which requires as little standing space as possible and which allows the relative orientation of the pump or pump connections to be flexibly adapted, the base is composed of several parts and consists of a first filter base adapted to the bottom of the filter container and of a second base arm which extends horizontally from the filter base in the radial direction and has a surface for receiving the pump. The filter base has several cavities around its circumference which constitute parts of a detachable connection system and which receive matching fastening means arranged at the end of the base arm for fastening the arm to the filter base.
Patent AT-E376723-T1 (AT)
Inventor: KREMM STEVEN
IPC: H04B1/16
Filed: 1997-09-26
Granted: 2007-11-15
Abstract: A method and apparatus for determining frequency offsets caused by oscillator error or Doppler effects in a user terminal (for example, a mobile wireless telephone) in a communication system. The system (100) includes at least one user terminal (124, 126) and a base station (112), or gateway (120, 122) for communicating with the user terminal (124, 126) through a satellite (116, 118) with predetermined known orbital positions or patterns. A communication signal (130, 132, 146, 148) is precorrected for known Doppler effects, such as between a gateway and a transferring satellite (146, 148), when used, and transmitted to a user terminal. The user terminal (124, 126) determines the signal frequency relative to a reference oscillator (240), and treats any detected difference as resulting completely from Doppler. The frequency difference is either transferred as data in reverse link transmissions (130, 132, 140, 142), or used as a pre-correction factor for such transmissions. The frequency of the reverse link user terminal signals is measured at the gateway (120, 122), again compensating for known Doppler effects, to provide a nominal error measurement. Measured frequency error or offsets are then divided in half to arrive at a Doppler shift error, or divided in half and scaled to the appropriate frequency to arrive at a user terminal oscillator error. The detected error can be transmitted to the user terminal (124, 126) for use in correcting the oscillator output frequency, or for adjusting the timing of, or time tracking for, the user terminal (124, 126). Alternatively, the detected error can be included as data in subsequent signals for use by gateways (120, 122) or base stations (112).
Patent AT-E215236-T1 (AT)
Inventor: KLEINSCHMIDT PETER
IPC: G09F9/00
Filed: 1997-10-21
Granted: 2002-04-15
Abstract: A process combines a video camera oriented onto a control panel and a display in the field of vision of the operator of a device who may not look away from his work, so that the control elements are displayed to him in the display. This process is useful for helping drivers of vehicles of all kinds, but also for helping operators of cranes, medical diagnosis equipment, control rooms and other technical apparatuses.
Patent AT-E236996-T1 (AT)
Inventor: JU JINGYUE
IPC: G01N21/78
Filed: 1997-12-12
Granted: 2003-04-15
Abstract: Sets of fluorescent energy transfer labels and methods for their use in multi component analysis, particularly nucleic acid enzymatic sequencing, are provided. In the subject sets, at least two of the labels are energy transfer labels comprising a common donor and acceptor fluorophore in energy transfer relationship separated by different distances and capable of providing distinguishable fluorescence emission patterns upon excitation at a common wavelength. The subject labels find particular use in a variety of multi-component analysis applications, such as probes in FISH and multi array analyses, as well as primers in nucleic acid enzymatic sequencing applications.
Patent AT-E265740-T1 (AT)
Inventor: HILFIKER PETER
IPC: H01H11/00
Filed: 1998-02-07
Granted: 2004-05-15
Abstract: The mechanical coupling device uses a hook (3) projecting from the housing of the overload relay (1) to fit into a corresponding opening in the housing of the protection switch (2), with a locking pin (5) projecting from at least one of the flat side faces at the end (4) of the hook. A rigid terminal pin (10) projects from the relay housing to cooperate with a terminal clamp (11) of the protection switch, the locking pin located upon reception of the terminal pin in the terminal clamp.
Patent AT-E273593-T1 (AT)
Inventor: CAPMAN FRANCOIS
IPC: H04M9/08
Filed: 1998-01-19
Granted: 2004-08-15
Abstract: The method involves applying a received signal (x(n)) to the input of an echo generating system (1). An observation signal ((z(n)) is picked up at the system output and the received signal is filtered to produce a signal (y(n)) which predicts the echo in the observation signal. The error prediction signal is subtracted from the observation signal to produce an error signal (e(n)). The observation signal is decomposed into a number (M) of spectral components which correspond to the different frequencies of the spectrum. Corresponding spectral components are obtained for an echo prediction signal, and values are calculated from the spectral components of the observation signal and the echo prediction signal. These values vary progressively according to the degree of similarity between the spectral components of the observation and prediction signals.